Fund Holdings — SUPERSTRING CAPITAL MANAGEMENT LP

Total Portfolio Value:
$186.78M
Total Bought:
$120.21M
Total Sold:
$69.37M
Net Transaction:
+$50.84M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Cidara Therapeutics Inc68,46385,098+16,635$6.56M$18.80M10.06%+$12.24M
Terns Pharmaceuticals Inc789,646443,777-345,869$5.93M$17.93M9.60%+$12.00M
UroGen Pharma Ltd.(URGN)87,912718,354+630,442$1.75M$16.82M9.01%+$15.07M
Cogent Biosciences, Inc.(COGT)361,408366,238+4,830$5.19M$13.01M6.96%+$7.82M
Dynavax Technologies Corp0525,592+525,592$0$8.08M4.33%+$8.08M
Sionna Therapeutics, Inc.(SION)0180,593+180,593$0$7.43M3.98%+$7.43M
Immunovant, Inc.(IMVT)341,348288,677-52,671$5.50M$7.34M3.93%+$1.84M
Axsome Therapeutics, Inc.(AXSM)037,433+37,433$0$6.84M3.66%+$6.84M
Savara Inc.(SVRA)1,309,236995,353-313,883$4.67M$6.00M3.21%+$1.33M
Mind Medicine Mindmed Inc0425,202+425,202$0$5.69M3.05%+$5.69M
Taysha Gene Therapies, Inc.(TSHA)0980,768+980,768$0$5.39M2.89%+$5.39M
Ocular Therapeutix, Inc.(OCUL)0418,080+418,080$0$5.08M2.72%+$5.08M
Amicus Therapeutics Inc
COM
0352,896+352,896$0$5.03M2.69%+$5.03M
Cabaletta Bio, Inc.(CABA)1,544,5252,253,550+709,025$3.61M$4.94M2.64%+$1.32M
United Therapeutics Corporation(UTHR)09,451+9,451$0$4.61M2.47%+$4.61M
Revolution Medicines, Inc.(RVMD)054,879+54,879$0$4.37M2.34%+$4.37M
Belite Bio, IncADS(BLTE)024,703+24,703$0$3.95M2.12%+$3.95M
Bright Minds Biosciences Inc.(DRUG)53,95047,278-6,672$3.27M$3.69M1.98%+$417.0K
Zai Lab LimitedADR(ZLAB)200,628196,853-3,775$6.80M$3.47M1.86%-$3.33M
Zenas BioPharma, Inc.(ZBIO)96,66583,353-13,312$2.15M$3.03M1.62%+$880.6K
IRulya Therapeutics Inc.(IRLA)0858,711+858,711$0$2.88M1.54%+$2.88M
Avalo Therapeutics, Inc.(AVTX)188,080153,313-34,767$2.39M$2.78M1.49%+$393.7K
Capricor Therapeutics, Inc.(CAPR)096,334+96,334$0$2.78M1.49%+$2.78M
Palvella Therapeutics, Inc.(PVLA)025,469+25,469$0$2.67M1.43%+$2.67M
Celldex Therapeutics, Inc.(CLDX)088,308+88,308$0$2.40M1.28%+$2.40M
Assembly Biosciences Inc065,273+65,273$0$2.22M1.19%+$2.22M
ORIC Pharmaceuticals, Inc.(ORIC)89,346255,370+166,024$1.07M$2.09M1.12%+$1.02M
Protara Therapeutics, Inc.(TARA)360,000360,0000$1.57M$1.92M1.03%+$352.8K
Trevi Therapeutics, Inc.(TRVI)0148,292+148,292$0$1.86M0.99%+$1.86M
Tyra Biosciences, Inc.(TYRA)058,677+58,677$0$1.54M0.83%+$1.54M
Travere Therapeutics, Inc.(TVTX)53,62738,022-15,605$1.28M$1.45M0.78%+$171.1K
Viridian Therapeutics, Inc.(VRDN)043,230+43,230$0$1.35M0.72%+$1.35M
Rezolute, Inc.(RZLT)0513,765+513,765$0$1.21M0.65%+$1.21M
Dianthus Therapeutics, Inc.(DNTH)026,249+26,249$0$1.08M0.58%+$1.08M
Spruce Biosciences Inc012,137+12,137$0$1.06M0.57%+$1.06M
Aardvark Therapeutics Inc069,496+69,496$0$912.1K0.49%+$912.1K
Genmab A/SADS(GMAB)029,162+29,162$0$898.2K0.48%+$898.2K
Palisade Bio, Inc.(PALI)0367,103+367,103$0$862.7K0.46%+$862.7K
Fulcrum Therapeutics, Inc.(FULC)072,060+72,060$0$815.0K0.44%+$815.0K
Ultragenyx Pharmaceutical Inc.(RARE)031,738+31,738$0$730.0K0.39%+$730.0K
Palatin Technologies, Inc.(PTN)033,971+33,971$0$522.5K0.28%+$522.5K
Inventiva S.A.ADS(IVA)0100,000+100,000$0$465.0K0.25%+$465.0K
Century Therapeutics, Inc.(IPSC)462,963462,9630$230.6K$460.6K0.25%+$230.0K
Biomea Fusion, Inc.(BMEA)250,000250,0000$505.0K$310.0K0.17%-$195.0K
Entera Bio Ltd.SHS(ENTX)017,142+17,142$0$33.3K0.02%+$33.3K
89bio Inc384,6520-384,652$5.65M$0—-$5.65M
Bicara Therapeutics Inc175,9020-175,902$2.78M$0—-$2.78M
BridgeBio Pharma, Inc.(BBIO)88,6580-88,658$4.60M$0—-$4.60M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)57,6440-57,644$729.2K$0—-$729.2K
NovaBridge BiosciencesADS(NBP)139,8860-139,886$528.8K$0—-$528.8K
Insmed Incorporated(INSM)19,7860-19,786$2.85M$0—-$2.85M
IQVIA Holdings Inc.(IQV)19,1140-19,114$3.63M$0—-$3.63M
Jazz Pharmaceuticals plcSHS USD(JAZZ)40,8930-40,893$5.39M$0—-$5.39M
Keros Therapeutics, Inc.(KROS)95,0830-95,083$1.50M$0—-$1.50M
Nektar Therapeutics(NKTR)51,2700-51,270$2.92M$0—-$2.92M
Protagonist Therapeutics Inc20,3580-20,358$1.35M$0—-$1.35M
Rapt Therapeutics Inc34,4490-34,449$888.4K$0—-$888.4K
Regeneron Pharmaceuticals, Inc.(REGN)6,4010-6,401$3.60M$0—-$3.60M
SanofiADR(SNY)50,4070-50,407$2.38M$0—-$2.38M
Scholar Rock Holding Corporation(SRRK)39,5210-39,521$1.47M$0—-$1.47M
Summit Therapeutics Inc.(SMMT)197,2530-197,253$4.08M$0—-$4.08M
Tectonic Therapeutic, Inc.(TECX)119,2860-119,286$1.87M$0—-$1.87M
uniQure N.V.SHS(QURE)33,1750-33,175$1.94M$0—-$1.94M
Vir Biotechnology, Inc.(VIR)150,3120-150,312$858.3K$0—-$858.3K
Page 1 of 1
SUPERSTRING CAPITAL MANAGEMENT LP — 13F Holdings — Q4 2025 | TickerTrail